This phenomenon is characterized by the aberrant localization of secretions and blebs on the basal surface of tumor cells, along with MUC1 (Mucin1) (EMA) immunostain expression, which distinguishes IMPC from other breast carcinoma subtypes. The gene discussed is MUC1; the disease is neoplasm.